Posterior lumbar interbody fusion is a therapeutic option for patients who suffer from pain and instability of the lumbar spine. The first account of the PLIF procedure was published by Jaslow 12 in 1946; this author used autograft bone wedges from the iliac crest as implants. When bone graft was used as a stand-alone device, however, there was a significant incidence of collapse and pseudarthrosis. 14 The techniques involved in the PLIF procedure have been refined and advanced since then with the addition of pedicle screw fixation to supplement lumbar fusion constructs as well as intervertebral cages or spacers developed to prevent the collapse and pseudarthrosis found in noninstrumented fusions. There have been many new developments in bone support prostheses, including resorbable polymer implants. One such polymer, HYDROSORB (Medtronic Sofamor Danek, Memphis, TN) has been evaluated as a promising material in spinal surgery.
The techniques involved in the PLIF procedure have been refined and advanced since then with the addition of pedicle screw fixation to supplement lumbar fusion constructs as well as intervertebral cages or spacers developed to prevent the collapse and pseudarthrosis found in noninstrumented fusions. There have been many new developments in bone support prostheses, including resorbable polymer implants. One such polymer, HYDROSORB (Medtronic Sofamor Danek, Memphis, TN) has been evaluated as a promising material in spinal surgery. 2 HYDROSORB is a polyhydroxy acid, a copolymer composed of a 70:30 ratio of poly(L-lactide) to poly(D,Llactide) that is characterized by a degradation time of 18 to 36 months. There is extensive experience with polyhydroxy acid implants in Europe. This material does not induce a significant inflammatory or allergic reaction and is biocompatible with the dura mater and neuronal cells (unpublished data). It is not well visualized on routine radiographic studies but can be seen clearly on CT scans and magnetic resonance images prior to resorption without causing image degradation. Its strength and degradation characteristics allow it to provide mechanical support to the anterior column, but it may reduce stress shielding of the developing interbody fusion by the gradual reduction in load-sharing capacity as the structural integrity of the device is lost.
There are no published studies documenting the longterm clinical outcome or fusion rates attained using bioabsorbable implants for PLIF. We present the first experience in a series of 27 patients whose a mean follow-up duration was 26 months, and we evaluate the safety and efficacy of this technique.
CLINICAL MATERIAL AND METHODS

Patient Population
Between May 2001 and August 2002, 27 patients underwent PLIF procedures in which rectangular HYDRO-SORB interbody spacers packed with locally harvested autograft bone were used. Of these procedures, 14 were single level fusions, six were two-level fusions, six were three-level fusions, and one was a four-level fusion; one Object. The goal of this prospective study was to review a series of 27 patients who underwent bilateral posterior lumbar interbody fusion with instrumented pedicle fixation and two HYDROSORB (known generically as 70:30 poly[L-lactide-co-D,L-lactide]) rectangular cages packed with locally harvested autograft at a total of 48 levels, and to assess the safety and efficacy of this novel technique. This analysis, conducted at a mean of 26 months of follow up, is the first report of a long-term evaluation of this technique. Fusion rates and clinical outcomes are presented.
Methods. A prospective clinical and radiographic review of findings in 27 consecutive patients was performed. Fusion rates and clinical outcome were assessed at 6-month intervals up to the 32-month follow-up end point. Two patients with four corresponding fusion levels were lost to follow up.
Radiographic evidence of satisfactory fusion was achieved in 42 (95.5%) of 44 levels fused. Satisfactory fusion at all levels was achieved in 23 (92%) of 25 patients. Two patients required repeated operations for treatment of symptomatic pseudarthrosis during the study period. The likelihood of all levels attaining fusion in a given patient decreased as the number of levels treated increased, which is consistent with previously published studies. Nonetheless, fusion rates per treated level were similar for patients in whom one to three levels were treated. No significant surgical complication occurred.
Conclusions. Posterior lumbar interbody fusion in which the HYDROSORB bioabsorbable implant packed with locally harvested autograft and segmental internal fixation are used appears to be an interbody fusion alternative whose efficacy is comparable with previously reported procedures. patient in the single-level and one in the three-level group were lost to follow up. The patients' characteristics, which include sex, age, tobacco use, Worker's compensation, and previous surgery, are presented in Table 1 .
All patients presented with a combination of mechanical low-back pain, neurogenic claudication, and a significant radicular component that was refractory to nonsurgical management. Radiographic indications for fusion included plain x-ray films showing instability and magnetic resonance images demonstrating degenerative changes, central or foraminal stenosis, and disc collapse. Patients were offered the opportunity to participate in a standardized clinical assessment program (PhDx Systems, Albuquerque, NM), and 21 patients elected to do so.
All patients underwent PLIF procedures with implantation of HYDROSORB devices packed with "morcellized" autograft bone harvested from the elements of decompression, followed by pedicle screw fixation and bilateral transverse process fusions. All procedures were performed by the senior author (C.L.B.).
Surgical Procedure
A midline incision was made and dissection was extended along the spinous process. Muscle stripping was performed to the level of the medial transverse process bilaterally just over the facet capsules. A bilateral hemilaminectomy decompression was created at the appropriate levels. Once the nerve root was identified, careful dissection was performed for visualization of the disc along the superior border of the pedicle. The target disc spaces were incised bilaterally and distracted with a disc space distractor. Intradiscal soft-tissue removal and endplate preparation were performed bilaterally according to the Tangent technique. A HYDROSORB device packed with locally harvested autologous morcellized bone graft was tamped into the disc space on one side. The center of the disc space was filled with morcellized graft and another HYDROSORB device was inserted on the second side.
Pedicle screws were placed in the pedicles of the appropriate levels, with bicortical purchase at S-1. Rods or plates were fixed to the pedicle screws in anatomical positions. Bone graft was then inserted over the transverse process of the lateral facet joint and the wound was closed in layers. Patients were instructed to wear a lumbar corset for 3 months.
Postoperative Evaluation
Patients in this series were evaluated for a minimum of 17 months, based on radiographs and physical examinations. We report the success of the fusion at individual levels as observed on plain radiographs and CT scans. Fusion was defined as trabecular bone bridging the interspace around or within the implant, with the absence of increased lucency around the implant. The assessment of fusion and stability based on plain radiographs and intermittent CT scanning was performed by the senior author and by radiologists at our institution. In this review, a patient with an incomplete fusion on CT scans who met the fusion criteria on plain radiographs and in whom there were no clinical or radiographic signs of a pseudarthrosis was assigned to the successful fusion group. Clinical outcomes were assessed prospectively based on results of patient examinations and data recordings before surgery, at surgery, and at 1-, 3-, and 6-month intervals after surgery. Evaluations at each interval included ratings of pain, function, medication usage, and patient satisfaction. More extensive details of the clinical outcomes, including Short Form-36 and other clinical assessment tools, will be published in a subsequent manuscript.
RESULTS
A summary of fusion rates and levels is found in Table  2 . Overall, successful fusion was achieved according to radiographic images at 42 (95.5%) of 44 levels. When analyzed by the number of levels fused per patient, all single-level fusions were successful (Fig. 1) . In two-level fusions, all 12 levels (100%) were successfully fused (Fig.  2) . In three-level fusions, 14 (93.3%) of 15 levels were successfully fused (Fig. 3 ). In the four-level fusion, three (75%) of four levels were successfully fused. Fusion success, when analyzed according to the number of patients undergoing single-or multiple-level fusions, revealed the following results. Single-and two-level fusions remained the same at 100%. In patients with three-level fusions, four (80%) of five attained successful fusions at all levels.
D. E. Couture and C. L. Branch, Jr. In the patient with a four-level fusion, there was a failure to fuse at one of the four levels. The probability of satisfactory fusion at all levels in a given patient decreased as the number of levels fused increased; this is consistent with previously published studies. 4 Yet, when fusion success was analyzed according to the number of levels fused per patient, the fusion rate remains similar, between 93.3 and 100% in single-to three-level fusions.
Pseudarthrosis or fusion failure occurred at the caudal end of a three-and a four-level fusion. These failures became evident and led to repeated surgery at 19 and 20 months after the index fusion procedure. Fusion failure was manifested by a sudden clinical deterioration associated with a disc space collapse, with varying degrees of cavitation or lucency around the HYDROSORB devices (Figs. 4 and 5) . At repeated operation there was no evidence of an inflammatory response but simply a fluidfilled void at the site of the HYDROSORB spacer. The remaining levels that appeared to be fused on radiographic studies were confirmed to be solid intraoperatively.
No significant surgical complication occurred; complications are listed in Table 3 . Dural tears, permanent nerve root injury, infection, and death rates are recorded. There were four incidental dural tears recognized and repaired at the time of surgery; there were no postoperative cerebrospinal fluid leaks. No patient sustained a permanent nerve root injury. There were no infectious complications or deaths in any of the groups.
Standardized clinical outcome assessment was confounded by the fact that only 21 of the patients included in this 27-patient cohort elected to participate in a standardized outcome assessment algorithm. Of these 21, 16 patients completed 12-month and eight completed 24-month surveys, the results of which are shown in Fig. 6 . All patients in the series reported a benefit derived from surgical treatment at the last follow-up review. It is difficult to confirm a statistically significant clinical benefit in this entire group by using these data, but that is not the intent of this report. No patient's condition was made worse.
DISCUSSION
The PLIF procedure accompanied by intervertebral spacers has an extensive history with a documented satisfactory fusion rate. 1, 4, 6, [9] [10] [11] [15] [16] [17] [18] [19] 21 We report the first 2-year follow-up study of a novel PLIF technique in which a biodegradable HYDROSORB interbody spacer was used.
Machine-prepared allograft bone in the form of wedges or threaded dowels has yielded a range of fusion results. 3 Determining satisfactory on fusion radiographic studies may be difficult in the case of both cortical allograft and metallic devices. In addition, allograft bone may take many years to be incorporated or may never be completely replaced by host bone.
Although single-level instrumented PLIF with interbody cages or spacers is associated with a consistently
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Posterior lumbar interbody fusion with bioabsorbable spacers high fusion rate, the type of cage may affect our ability to determine fusion status and it may potentially impact clinical outcome. Agazzi, et al., 1 reported a 90% fusion rate after 28 months of follow up in 71 consecutive patients treated with metallic cages; the overall satisfaction rate was 67%, with only 39% good or excellent results. Brantigan, et al., 4 reported better results, with a fusion rate of 98.9% in 178 patients and a clinical success rate of 86%. Carbon fiber or other synthetic cages are relatively radiolucent, yet the difficulties involved in the radiographic assessment of fusion with metallic intervertebral cages is an inherent limitation of many currently used devices. 7, 8, 13, 20 These limitations led to the development of biological spacers that provide immediate spinal stability, are radiolucent, and are ultimately biodegradable. The HYDRO-SORB biodegradable device allows more accurate assessment of fusion on conventional radiographic studies but imposes a time frame on the fusion process. In this early experience, the PLIF procedure with the HYDROSORB device appears to result in fusion rates that are comparable to those previously reported.
Expected fusion levels in both the single-and multiplelevel fusion groups were attained. Clinical outcomes in this series appear to be consistent with those obtained using crushed cortical allograft bone preparations, although an extensive analysis of clinical outcome is outside the scope of this brief communication. The multiple-level pseudarthrosis rate was higher than in single-level fusions, as was found in previous studies, 4, 5 in which a 25 to 30% pseudarthrosis in multiple-level fusion was reported. After 12 months, HYDROSORB devices begin to develop a consistent loss of strength due to resorption. If adequate fusion has not occurred within that time frame, there is increasing potential for disc space collapse with pseudarthrosis.
Analysis of data obtained in animal models indicates that at 12 months the HYDROSORB device retains 95% of its structural integrity, yet in the face of the loads and motion caused by a subsequent fusion failure the biodegradation appears to increase, resulting in an appearance of cavitation comparable to the lucencies that appear around metallic or other devices in which a solid fusion has not been achieved. 7, 8, 13, 20 The exact mechanism or mechanisms associated with this somewhat striking cavitation appear- ance seen in conjunction with the bioabsorbable device certainly warrants further analysis.
Adequate interbody bone grafting in addition to implantation of the spacers optimizes the fusion process and appears to minimize the potential for fusion failure as the biodegradation of the device accelerates at 18 months. In our series, it appears that the fusion failures were consequences of inadequate interbody bone grafting or insufficient sacral fixation, especially at the extremes of a multiple-level fusion. These findings warrant further analysis of the efficacy of a bioabsorbable device in a patient with metabolic or structural characteristics that would retard the fusion process. We did recognize solid fusions in elderly women in whom multiple levels were fused.
In the patients who underwent single level fusions, two were found to have adjacent level disease during followup visits. Both of these patients underwent a single-level fusion at the adjacent level. A solid fusion was confirmed intraoperatively at the level previously fused. One of these
Posterior lumbar interbody fusion with bioabsorbable spacers patients went on to do well, whereas in the other a pseudarthrosis developed at the new level, which required a repeated operation; this patient's spinal column appeared to be fused at 12-month analysis.
We acknowledge that our study involves a small cohort documenting an early experience with a novel PLIF technique. This study does not include an outside independent review of the follow-up radiographs, yet the radiographic fusion rates documented here are consistent with previous reports and the integrity of the fusion was validated surgically in the cases in which a pseudarthrosis adjacent to a solid fusion was revised. We believe that the accuracy of our interpretation was facilitated by the radiolucent device used.
CONCLUSIONS
Our experience treating this small series of patients demonstrates that HYDROSORB bioabsorbable devices may be used to achieve satisfactory fusion rates and outcomes when used for PLIF procedures. The safety and efficacy of these devices appears to be comparable with other types of implants. We achieved expected fusion levels in single-and multiple-level groups. We recognize the time limitations imposed on the fusion process by a biodegradable support device; this warrants further analysis. The HYDROSORB implants appear to facilitate radiographic assessment of fusion, especially when compared with metallic devices.
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